(UroToday.com) Given the drastic measures to protect patients and physicians during the COVID-19 pandemic, we have seen a rapid increase in the utilization of teleconsultation for patients with urologic malignancies. At the 2020 European Association of Urology (EAU) Section of Oncological Urology (ESOU) Virtual Annual Meeting, Dr. Juan Gomez Rivas discussed the preliminary assessment of patient and physician satisfaction with the use of teleconsultation in urology during the COVID-19 pandemic. Dr. Gomez Rivas notes that there are four stakeholders when discussing teleconsultations, including (i) patients and their families, (ii) physicians and other healthcare providers, (iii) healthcare facilities, and (iv) insurance companies. For patients and their families there are many benefits: